Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN.

Organisations Organisation Beckman Coulter Inc., Life Science Division (Beckman Coulter Life Sciences)
  Group Danaher (Group)
  Organisation 2 Labcyte Inc.
  Group Danaher (Group)
Product Product  acoustic droplet ejection technology (ADE technology)
Index term Index term Labcyte–Danaher: investment, 201901 acquisition of Labcyte by Beckman Coulter Life Sciences
Persons Person Pratt, Jonathan (Danaher 201901 President of Beckman Coulter Life Sciences)
  Person 2 Ellson, Richard (Labcyte 200703 CTO)
     


Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.

Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with unequalled speed and accuracy. This technology—the centerpiece of Labcyte’s Echo Liquid Handlers—enables walkaway convenience and integration capabilities. Labcyte technology enables faster and more cost-effective laboratory workflows in applications such as drug discovery and genomics.

“Labcyte’s unique product portfolio complements our existing liquid handling and laboratory automation business. It provides new opportunities to develop and enhance time-saving solutions for customer workflows,” said Jonathan Pratt, President, Beckman Coulter Life Sciences. “Labcyte and Beckman Coulter Life Sciences share a common vision of advancing science through discovery, enabling the faster discovery and development of life-changing advances in medicine. Together we will make a powerful team, and an invaluable resource for current and future customers around the world.”

“It has been an exciting journey—from developing acoustic liquid-dispensing technology in a garage to establishing a global presence, and now to be joining forces with a life sciences technology leader,” said Richard Ellson, CTO and a Founder of Labcyte. “Acoustic liquid handling is quickly becoming the backbone for high-throughput, automated workflows, and we look forward to accelerating growth and innovation as part of the Beckman Coulter Life Sciences team.”

Labcyte will transition into Beckman Coulter Life Sciences under the larger Danaher Life Sciences platform of companies, which generates approximately $6.5 billion in annual revenue.


About Labcyte, Inc.

Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 63 U.S. patents and others internationally.

   
Record changed: 2019-02-03

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Danaher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top